New protein kinase CK2 inhibitors: jumping out of the catalytic box
- PMID: 19246001
- DOI: 10.1016/j.chembiol.2009.01.004
New protein kinase CK2 inhibitors: jumping out of the catalytic box
Abstract
Protein kinases are central components of signal transduction cascades often dysregulated in cancer, and they represent some of the most promising drug targets. However, the target selectivity is a major concern because most described kinase inhibitors target the highly conserved ATP-binding pocket. Recently, new classes of inhibitors that do not compete with ATP and exhibit different mechanisms of action have been described. Overexpression of protein kinase CK2 is an unfavorable prognostic marker in several cancers. Consequently, CK2 has emerged as a relevant therapeutic target. Several classes of ATP-competitive inhibitors have been identified, showing variable effectiveness. The molecular architecture of this multisubunit enzyme could offer alternative strategies to inhibit CK2 functions, and this review illustrates these emerging possibilities.
Similar articles
-
Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2.Chem Biol. 2008 Jul 21;15(7):683-92. doi: 10.1016/j.chembiol.2008.05.018. Chem Biol. 2008. PMID: 18635005
-
Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2.Bioorg Med Chem Lett. 2007 Aug 1;17(15):4191-5. doi: 10.1016/j.bmcl.2007.05.041. Epub 2007 May 18. Bioorg Med Chem Lett. 2007. PMID: 17540560
-
The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.Chem Biol. 2008 Feb;15(2):111-7. doi: 10.1016/j.chembiol.2007.12.012. Chem Biol. 2008. PMID: 18291315
-
Protein kinase CK2 as a druggable target.Mol Biosyst. 2008 Sep;4(9):889-94. doi: 10.1039/b805534c. Epub 2008 Jun 12. Mol Biosyst. 2008. PMID: 18704226 Review.
-
A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding.Drug Discov Today. 2007 Aug;12(15-16):622-33. doi: 10.1016/j.drudis.2007.06.008. Epub 2007 Aug 2. Drug Discov Today. 2007. PMID: 17706543 Review.
Cited by
-
Disrupting the Constitutive, Homodimeric Protein-Protein Interface in CK2β Using a Biophysical Fragment-Based Approach.J Am Chem Soc. 2016 Nov 2;138(43):14303-14311. doi: 10.1021/jacs.6b07440. Epub 2016 Oct 20. J Am Chem Soc. 2016. PMID: 27726344 Free PMC article.
-
Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer.PLoS One. 2010 Jul 2;5(7):e11418. doi: 10.1371/journal.pone.0011418. PLoS One. 2010. PMID: 20625391 Free PMC article.
-
Protein kinase CK2 and ion channels (Review).Biomed Rep. 2020 Dec;13(6):55. doi: 10.3892/br.2020.1362. Epub 2020 Sep 30. Biomed Rep. 2020. PMID: 33082952 Free PMC article. Review.
-
GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.Nat Immunol. 2024 Feb;25(2):282-293. doi: 10.1038/s41590-023-01691-y. Epub 2024 Jan 3. Nat Immunol. 2024. PMID: 38172257
-
Structural basis for decreased affinity of Emodin binding to Val66-mutated human CK2 alpha as determined by molecular dynamics.J Mol Model. 2010 Apr;16(4):771-80. doi: 10.1007/s00894-009-0582-2. Epub 2009 Oct 11. J Mol Model. 2010. PMID: 19821123
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources